SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September
Skyline Medical Inc.
(Exact name of Registrant as Specified in
(State or Other Jurisdiction of Incorporation)
|(Commission File Number)
||(IRS Employer Identification No.)|
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
(Address of Principal Executive Offices
and Zip Code)
(Registrant’s telephone number, including
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 5.03 Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.
On September 16, 2016, the Certificate of
Incorporation of Skyline Medical Inc. (the “Company”) was amended to increase the authorized capital stock from 100,000,000
shares to 200,000,000 shares of common stock, $0.01 par value. The Certificate of Amendment is filed as Exhibit 3.1.
Item 5.07 Submission of Matters to a Vote of Security Holders.
At a special meeting of stockholders taking
place on September 15, 2016, the Company’s stockholders took the following actions:
(i) The stockholders approved an amendment
to the Company’s certificate of incorporation to increase the number of authorized shares of common stock from 100,000,000
to 200,000,000. There were 41,902,941 votes cast for the proposal; 14,992,050 votes were cast against the proposal, and 571,184
votes abstained. There were no broker non-votes.
(ii) The stockholders approved an amendment
to the Company’s certificate of incorporation to effect a reverse stock split of the outstanding shares of its common stock
at a ratio of not less than one-for-two (1:2) and not more than one-for-twenty-five (1:25), with the exact ratio to be set at a
whole number within this range as determined by the Company’s Board of Directors. There were 43,248,274 votes cast for the
proposal; 13,811,359 votes were cast against the proposal, and 406,542 votes abstained. There were no broker non-votes.
(iii) The stockholders approved a proposal
to adjourn the Special Meeting, if necessary, to solicit additional proxies if there were not sufficient votes at the time of the
Special Meeting to approve both the proposal to increase the authorized shares of common stock (Proposal 1) and the proposal to
effect a reverse stock split (Proposal 2). There were 41,673,190 votes cast for the proposal; 14,579,044 votes were cast against
the proposal, and 1,213,941 votes abstained. There were no broker non-votes.
Item 9.01 Financial Statements and
||Certificate of Amendment filed September 16, 2016|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 16, 2016
||SKYLINE MEDICAL, INC.
||/s/ Bob Myers
Chief Financial Officer